March 18, 2018 1:43 AM ET


Company Overview of Pall Corporation

Company Overview

Pall Corporation manufactures and markets filtration, separation, and purification products; and integrated systems solutions worldwide. Its Life Sciences segment provides technologies that facilitate the process of drug discovery, development, regulatory validation, and production, which are used in the research laboratories, pharmaceutical, biotechnology, and food and beverage industries, as well as in hospitals. It offers medical products to control the spread of infections in hospitals; cell therapy products; and filtration and purification technologies, associated hardware, and engineered systems for the development and commercialization of drugs, plasma, and vaccines. This segment also...

25 Harbor Park Drive

Port Washington, NY 11050

United States

Founded in 1946





Key Executives for Pall Corporation

Chief Financial Officer
Group Vice President and President of Pall Life Sciences
Age: 52
President of Pall Industrial
Age: 48
President of Pall China
Compensation as of Fiscal Year 2017.

Pall Corporation Key Developments

Orgenesis Ltd. and Pall Corporation Partnership Accomplishes Project Financed by the BIRD Foundation

Orgenesis Ltd. announced that Orgenesis and Pall Corporation have completed their joint development program supported by the Israel-U.S. Binational Industrial Research and Development Foundation. Orgenesis is focused on developing an innovative autologous cell-based therapy for the treatment of diabetes.

Pall Corporation Presents at 4th Op-Ex Russia & CIS 2017, Nov-15-2017

Pall Corporation Presents at 4th Op-Ex Russia & CIS 2017, Nov-15-2017 . Venue: Swissotel Resort Sochi Kamelia, Sochi, Russia. Speakers: Andrey Chernyshev, Head of Refining Department.

Wuxi Biologics and Pall Corporation Establish Joint Continuous Bioprocess Laboratory

WuXi Biologics and its partner Pall Corporation established a joint laboratory to develop full continuous processing for the manufacturing of monoclonal antibodies (mAb). The 3-year project started with the continuous operation of individual processes and will gradually be expanded to downstream processing development and production. The joint laboratory will serve WuXi Biologics' customers worldwide in an attempt to significantly reduce mAb drugs' manufacturing costs and benefit patients around the world. An opening ceremony for the WuXi Biologics and Pall joint laboratory was held by the two parties on November 2, 2017. The joint laboratory, constructed with Pall Life Sciences' unique CadenceTM Integrated Continuous Bioprocess System and integrated with its single-use technology platform, ensures process flexibility, facilitates switches between processes and avoids cross-contamination, thereby enabling pharmaceutical companies to reduce the manufacturing space required at a facility and to reduce cost. After years of intensive efforts on technological development, WuXi Biologics has developed high-yielding cell lines and laboratory-scale continuous processes, significantly increasing the expression of some mAbs to up to equivalent of 40-50 g/L in the traditional fed-batch process, which is approximately 10 times more productive than the typical fed-batch process.

Similar Private Companies By Industry

Company Name Region
+Vantage Corporation United States
101 Imports, Inc. United States
21st Century Energy, Inc. United States
360 Yield Center, LLC United States
3DEO, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
Tax Management Inc United States
John F. Kennedy Center For The Performing Arts United States
NYC2012, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Pall Corporation, please visit Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at